| Acanthamoeba castellanii |
Acanthamoeba castellanii |
IC50 |
1562.5 |
nM |
10.1128/aac.00355-07 |
| Acanthamoeba castellanii |
Acanthamoeba castellanii |
Inhibition |
nan |
% |
10.1016/j.ejmech.2019.111575 |
| Acanthamoeba polyphaga |
Acanthamoeba polyphaga |
IC50 |
3125.0 |
nM |
10.1128/aac.00355-07 |
| Acinetobacter baumannii |
Acinetobacter baumannii |
MIC |
16.0 |
ug.mL-1 |
10.1128/aac.00748-09 |
| Acinetobacter baumannii |
Acinetobacter baumannii |
MIC |
32.0 |
ug.mL-1 |
10.1128/aac.00748-09 |
| Acinetobacter baumannii |
Acinetobacter baumannii |
Ratio |
2.0 |
None |
10.1128/aac.00748-09 |
| Actinomyces naeslundii |
Actinomyces naeslundii |
PBI |
19.2 |
None |
10.1021/jm00377a014 |
| Actinomyces viscosus |
Actinomyces viscosus |
Concentration |
1.6 |
mM |
10.1021/jm00377a014 |
| Actinomyces viscosus |
Actinomyces viscosus |
MBC |
0.5 |
ug ml-1 |
10.1021/jm00384a035 |
| Actinomyces viscosus |
Actinomyces viscosus |
PBI |
19.2 |
None |
10.1021/jm00118a030 |
| Actinomyces viscosus |
Actinomyces viscosus |
PBI |
19.2 |
None |
10.1021/jm00377a014 |
| Aggregatibacter actinomycetemcomitans |
Aggregatibacter actinomycetemcomitans |
MBC |
0.5 |
ug ml-1 |
10.1021/jm00384a035 |
| Bacillus anthracis |
Anthrax lethal factor |
Potency |
31622.8 |
nM |
None |
| Bacillus subtilis |
4'-phosphopantetheinyl transferase ffp |
Potency |
44668.4 |
nM |
None |
| Bacillus subtilis |
Bacillus subtilis |
MIC |
1.0 |
ug.mL-1 |
10.1016/j.ejmech.2020.113100 |
| Bacillus subtilis |
Bacillus subtilis |
MIC |
1.5 |
ug.mL-1 |
10.1016/j.ejmech.2022.114632 |
| Bacillus subtilis |
Bacillus subtilis |
MIC |
2.0 |
ug.mL-1 |
10.1016/j.bmc.2020.115905 |
| Burkholderia cepacia |
Burkholderia cepacia |
Activity |
500.0 |
ug ml-1 |
10.1016/S0960-894X(97)00297-7 |
| Candida albicans |
Candida albicans |
IC50 |
21800.0 |
nM |
10.1021/acs.jmedchem.6b01203 |
| Candida albicans |
Candida albicans |
Inhibition |
49.9 |
% |
10.1016/j.bmcl.2016.01.082 |
| Candida albicans |
Candida albicans |
MIC |
1.5 |
ug.mL-1 |
10.1128/aac.00860-09 |
| Candida albicans (strain WO-1) (Yeast) |
ATP-dependent molecular chaperone HSP82 |
EC50 |
2128.0 |
nM |
None |
| Candida albicans (strain WO-1) (Yeast) |
ATP-dependent molecular chaperone HSP82 |
EC50 |
150000.0 |
nM |
None |
| Candida dubliniensis (strain CD36 / CBS 7987 / NCPF 3949 / NRRLY-17841) (Yeast) |
Serine/threonine-protein phosphatase |
EC50 |
180000.0 |
nM |
None |
| Chlorocebus sabaeus |
Vero |
CC50 |
8430.0 |
nM |
None |
| Enterococcus faecalis |
Enterococcus faecalis |
Activity |
160.0 |
ug ml-1 |
10.1016/S0960-894X(97)00297-7 |
| Escherichia coli |
Escherichia coli |
Activity |
20.0 |
ug ml-1 |
10.1016/S0960-894X(97)00297-7 |
| Escherichia coli |
Escherichia coli |
Activity |
80.0 |
ug ml-1 |
10.1016/S0960-894X(97)00297-7 |
| Escherichia coli |
Escherichia coli |
FC |
5.0 |
None |
10.1039/C0MD00247J |
| Escherichia coli |
Escherichia coli |
MIC |
0.5 |
ug.mL-1 |
10.1021/jm00377a014 |
| Escherichia coli |
Escherichia coli |
MIC |
1.0 |
ug.mL-1 |
10.1016/j.bmc.2020.115905 |
| Escherichia coli |
Escherichia coli |
MIC |
1.0 |
ug.mL-1 |
10.1016/j.ejmech.2020.113100 |
| Escherichia coli |
Escherichia coli |
MIC |
1.0 |
ug.mL-1 |
10.1021/jm00377a014 |
| Escherichia coli |
Escherichia coli |
MIC |
1.5 |
ug.mL-1 |
10.1016/j.ejmech.2022.114632 |
| Escherichia coli |
Escherichia coli |
MIC |
2.0 |
ug.mL-1 |
10.1128/aac.00748-09 |
| Escherichia coli |
Escherichia coli |
MIC |
4.0 |
ug.mL-1 |
10.1128/aac.00748-09 |
| Escherichia coli |
Escherichia coli |
Ratio |
2.0 |
None |
10.1128/aac.00748-09 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
4098.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
600.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
607.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
4342.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
2400.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
1800.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-synuclein |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Androgen Receptor |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Androgen Receptor |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase, type II |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
1400.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
6499.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-glucocerebrosidase |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Beta-glucocerebrosidase |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Beta-glucocerebrosidase |
Potency |
16343.3 |
nM |
None |
| Homo sapiens |
Beta-glucocerebrosidase |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Bile acid receptor FXR |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Bile salt export pump |
AC50 |
170000.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
3073.5 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Casein kinase I epsilon |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.2c02068 |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
7.9 |
nM |
None |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
70794.6 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
15900.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclin-dependent kinase 5/CDK5 activator 1 |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.2c02068 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
15848.93 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
7943.28 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
15848.93 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
7943.28 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
DNA polymerase kappa |
Potency |
21192.3 |
nM |
None |
| Homo sapiens |
DNA repair protein RAD52 homolog |
AC50 |
1700.0 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
4200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
3200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
3000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dual specificity protein kinase CLK2 |
IC50 |
9165.0 |
nM |
10.1021/acs.jmedchem.2c02068 |
| Homo sapiens |
Dual specificity protein kinase CLK3 |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.2c02068 |
| Homo sapiens |
Dual specificity protein kinase CLK4 |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.2c02068 |
| Homo sapiens |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.2c02068 |
| Homo sapiens |
Dual specificity tyrosine-phosphorylation-regulated kinase 1B |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.2c02068 |
| Homo sapiens |
Dual-specificity tyrosine-phosphorylation regulated kinase 2 |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.2c02068 |
| Homo sapiens |
Dual-specificity tyrosine-phosphorylation regulated kinase 3 |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.2c02068 |
| Homo sapiens |
Dual specificity tyrosine-phosphorylation-regulated kinase 4 |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.2c02068 |
| Homo sapiens |
Dual specificty protein kinase CLK1 |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.2c02068 |
| Homo sapiens |
Endothelin receptor ET-A |
Activity |
79.0 |
% |
10.1021/np900287e |
| Homo sapiens |
Endothelin receptor ET-A |
Activity |
100.0 |
% |
10.1021/np900287e |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Estrogen receptor alpha |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Fibroblast |
CC50 |
6.32 |
ug.mL-1 |
10.1016/j.ejmech.2020.113100 |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
29092.9 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
33498.3 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
1000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
Potency |
354.8 |
nM |
None |
| Homo sapiens |
Glucocorticoid receptor |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Glutathione reductase |
Ki |
192000.0 |
nM |
10.1021/jm050027z |
| Homo sapiens |
Glutathione reductase |
Ki' |
210.0 |
uM |
10.1021/jm050027z |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.2c02068 |
| Homo sapiens |
HEK293 |
CC50 |
7.28 |
ug.mL-1 |
10.1016/j.ejmech.2020.113100 |
| Homo sapiens |
Hepatocyte nuclear factor 4-alpha |
IC50 |
23461.0 |
nM |
None |
| Homo sapiens |
HepG2 |
IC50 relative |
4600.0 |
nM |
10.6019/EOS300108 |
| Homo sapiens |
HERG |
AC50 |
16293.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-31.73 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
0.25 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Huntingtin |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Importin subunit beta-1/Snurportin-1 |
Potency |
51735.2 |
nM |
None |
| Homo sapiens |
Interleukin-8 |
Potency |
74978.0 |
nM |
None |
| Homo sapiens |
Isocitrate dehydrogenase [NADP] cytoplasmic |
Potency |
14581.0 |
nM |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
3993.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4A |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Matrix metalloproteinase-2 |
IC50 |
7630.0 |
nM |
10.1016/j.bmcl.2009.12.059 |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
7630.0 |
nM |
10.1016/j.bmcl.2009.12.059 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
490.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
271.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
1997.0 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
784.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug and toxin extrusion protein 1 |
IC50 |
700.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Multidrug and toxin extrusion protein 1 |
Inhibition |
86.0 |
% |
10.1021/jm301302s |
| Homo sapiens |
Multidrug and toxin extrusion protein 2 |
IC50 |
500.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Mu opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
12999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
14000.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
7799.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
2200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Activity |
81.0 |
% |
10.1021/np900287e |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Activity |
100.0 |
% |
10.1021/np900287e |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
409.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
17228.9 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
23109.3 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
24336.5 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
33491.5 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
76958.8 |
nM |
None |
| Homo sapiens |
Nuclear factor NF-kappa-B p105 subunit |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Nuclear receptor ROR-gamma |
Potency |
26603.2 |
nM |
None |
| Homo sapiens |
Paired box protein Pax-8 |
AC50 |
5690.0 |
nM |
None |
| Homo sapiens |
Perilipin-1 |
IC50 |
2312.0 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Potency |
63095.7 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
10999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
POU domain, class 2, transcription factor 1 |
Inhibition |
99.2 |
% |
10.1021/acs.jmedchem.2c01075 |
| Homo sapiens |
POU domain, class 2, transcription factor 2 |
Inhibition |
104.8 |
% |
10.1021/acs.jmedchem.2c01075 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
3700.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
35.5 |
nM |
None |
| Homo sapiens |
Prelamin-A/C |
Potency |
1778.3 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
21899.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Putative hexokinase HKDC1 |
IC50 |
8990.0 |
nM |
None |
| Homo sapiens |
Putative hexokinase HKDC1 |
IC50 |
80000.0 |
nM |
None |
| Homo sapiens |
Rap guanine nucleotide exchange factor 4 |
Potency |
100000.0 |
nM |
None |
| Homo sapiens |
Retinoid X receptor alpha |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Retinoid X receptor alpha |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
8300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
1833.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
683.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
1264.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
5400.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
5900.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
1000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier family 22 member 1 |
IC50 |
210.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Solute carrier family 22 member 2 |
IC50 |
400.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Solute carrier family 22 member 3 |
IC50 |
410.0 |
nM |
10.1021/jm301302s |
| Homo sapiens |
Solute carrier family 22 member 3 |
Inhibition |
98.4 |
% |
10.1021/acs.jmedchem.2c01075 |
| Homo sapiens |
Sphingomyelin phosphodiesterase |
Potency |
89125.1 |
nM |
None |
| Homo sapiens |
Synaptojanin-1 |
IC50 |
15900.0 |
nM |
None |
| Homo sapiens |
Synaptojanin-2 |
IC50 |
10000.0 |
nM |
None |
| Homo sapiens |
TAR DNA-binding protein 43 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Transcriptional regulator ERG |
Potency |
5623.4 |
nM |
None |
| Homo sapiens |
Transcriptional regulator ERG |
Potency |
112201.8 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
12995.3 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
16360.1 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
18837.5 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
26608.6 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
Ubiquitin-conjugating enzyme E2 N |
IC50 |
2197.0 |
nM |
None |
| Homo sapiens |
Ubiquitin-conjugating enzyme E2 N |
IC50 |
3012.0 |
nM |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
14700.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
3900.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vitamin D receptor |
Potency |
44668.4 |
nM |
None |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 integrase |
Inhibition |
50.0 |
% |
10.1021/jm990322h |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
2.0 |
ug.mL-1 |
10.1016/j.bmc.2020.115905 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
3.9 |
ug.mL-1 |
10.1021/jm00377a014 |
| Lactiplantibacillus plantarum |
Lactiplantibacillus plantarum |
MIC |
10.0 |
ug.mL-1 |
10.1021/acs.jnatprod.1c01093 |
| Micrococcus luteus |
Micrococcus luteus |
MIC |
0.5 |
ug.mL-1 |
10.1016/j.ejmech.2020.113100 |
| Mus musculus |
Bcl-2-related protein A1 |
IC50 |
20000.0 |
nM |
None |
| Mus musculus |
HT-22 |
IC50 |
5600.0 |
nM |
10.1021/acs.jmedchem.2c02068 |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
3548.1 |
nM |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
12589.3 |
nM |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
15848.9 |
nM |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
35481.3 |
nM |
None |
| Photinus pyralis |
Luciferin 4-monooxygenase |
Potency |
40533.4 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
151.0 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
207.9 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
329.4 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
849.2 |
nM |
None |
| Porphyromonas gingivalis |
Porphyromonas gingivalis |
MBC |
0.05 |
ug ml-1 |
10.1021/jm00384a035 |
| Porphyromonas gingivalis |
Porphyromonas gingivalis |
MBC |
31.3 |
uM |
10.1021/acs.jnatprod.9b01045 |
| Porphyromonas gingivalis |
Porphyromonas gingivalis |
MIC |
0.312 |
ug.mL-1 |
10.1021/np9901579 |
| Porphyromonas gingivalis |
Porphyromonas gingivalis |
MIC |
4.0 |
ug.mL-1 |
10.1016/j.bmcl.2014.10.039 |
| Porphyromonas gingivalis |
Porphyromonas gingivalis |
MIC |
6000.0 |
nM |
10.1016/j.ejmech.2007.11.001 |
| Porphyromonas gingivalis |
Porphyromonas gingivalis |
MIC |
15600.0 |
nM |
10.1021/acs.jnatprod.9b01045 |
| Proteus mirabilis |
Proteus mirabilis |
MIC |
15.6 |
ug.mL-1 |
10.1021/jm00377a014 |
| Providencia stuartii |
Providencia stuartii |
MIC |
0.0007 |
ug.mL-1 |
10.1016/j.ejmech.2021.113726 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Activity |
100.0 |
ug ml-1 |
10.1016/S0960-894X(97)00297-7 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Activity |
160.0 |
ug ml-1 |
10.1016/S0960-894X(97)00297-7 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Activity |
nan |
None |
10.1128/aac.01072-08 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
0.625 |
ug.mL-1 |
10.1128/aac.01072-08 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
1.25 |
ug.mL-1 |
10.1128/aac.01072-08 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
2.5 |
ug.mL-1 |
10.1128/aac.01072-08 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
4.0 |
ug.mL-1 |
10.1016/j.bmc.2020.115905 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
4.0 |
ug.mL-1 |
10.1016/j.ejmech.2020.113100 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
5.0 |
ug.mL-1 |
10.1128/aac.01072-08 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
10.0 |
ug.mL-1 |
10.1128/aac.01072-08 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
15.6 |
ug.mL-1 |
10.1021/jm00377a014 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
20.0 |
ug.mL-1 |
10.1128/aac.01072-08 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
50.0 |
ug.mL-1 |
10.1128/aac.01072-08 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
INS1 |
AC50 |
4674.0 |
nM |
None |
| Rattus norvegicus |
Nuclear receptor subfamily 1 group I member 2 |
Potency |
44668.4 |
nM |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
32196.8 |
nM |
None |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Potency |
17782.8 |
nM |
None |
| Saccharomyces cerevisiae S288c |
CAAX prenyl protease 2 |
AC50 |
5694.0 |
nM |
None |
| Serratia marcescens |
Serratia marcescens |
Activity |
40.0 |
ug ml-1 |
10.1016/S0960-894X(97)00297-7 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
-6.49 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.08739 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.27 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
-0.07742 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
Activity |
3.0 |
deltalog10CFU/ml |
10.1021/acs.jmedchem.5b01129 |
| Staphylococcus aureus |
Staphylococcus aureus |
Activity |
100.0 |
ug ml-1 |
10.1016/S0960-894X(97)00297-7 |
| Staphylococcus aureus |
Staphylococcus aureus |
Activity |
160.0 |
ug ml-1 |
10.1016/S0960-894X(97)00297-7 |
| Staphylococcus aureus |
Staphylococcus aureus |
FC |
2.5 |
None |
10.1039/C0MD00247J |
| Staphylococcus aureus |
Staphylococcus aureus |
FC |
8.0 |
None |
10.1128/aac.00430-07 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
0.2 |
ug.mL-1 |
10.1021/jm00377a014 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
2.0 |
ug.mL-1 |
10.1016/j.bmc.2020.115905 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
2.0 |
ug.mL-1 |
10.1016/j.ejmech.2020.113100 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
2.5 |
ug.mL-1 |
10.1021/acs.jnatprod.1c01093 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC50 |
0.31 |
ug.mL-1 |
10.1128/aac.00430-07 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC90 |
0.63 |
ug.mL-1 |
10.1128/aac.00430-07 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
Activity |
0.0 |
CFU/ml |
10.1021/acs.jnatprod.5b00833 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
Activity |
1.3 |
10'6CFU/ml |
10.1021/acs.jnatprod.5b00833 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
Activity |
4.0 |
10'3CFU/ml |
10.1021/acs.jnatprod.5b00833 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
Activity |
7.0 |
log10CFU/ml |
10.1021/acs.jnatprod.5b00833 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
Activity |
40.0 |
ug ml-1 |
10.1016/S0960-894X(97)00297-7 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
Activity |
nan |
None |
10.1021/acs.jnatprod.5b00833 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
Inhibition |
nan |
% |
10.1021/acs.jnatprod.5b00833 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MIC |
1.0 |
ug.mL-1 |
10.1016/j.bmc.2020.115905 |
| Streptococcus gordonii |
Streptococcus gordonii |
Inhibition |
95.0 |
% |
10.1128/aac.01391-09 |
| Streptococcus mitis |
Streptococcus mitis |
Inhibition |
95.0 |
% |
10.1128/aac.01391-09 |
| Streptococcus mutans |
Streptococcus mutans |
Activity |
nan |
None |
10.1021/acs.jnatprod.1c01093 |
| Streptococcus mutans |
Streptococcus mutans |
Concentration |
3.2 |
mM |
10.1021/jm00377a014 |
| Streptococcus mutans |
Streptococcus mutans |
Inhibition |
34.5 |
% |
10.1128/aac.00999-06 |
| Streptococcus mutans |
Streptococcus mutans |
Inhibition |
93.6 |
% |
10.1016/j.bmcl.2016.01.082 |
| Streptococcus mutans |
Streptococcus mutans |
Inhibition |
95.0 |
% |
10.1128/aac.01391-09 |
| Streptococcus mutans |
Streptococcus mutans |
Inhibition |
103.5 |
% |
10.1128/aac.00999-06 |
| Streptococcus mutans |
Streptococcus mutans |
Inhibition |
nan |
% |
10.1128/aac.01391-09 |
| Streptococcus mutans |
Streptococcus mutans |
log(1/MIC) |
5.22 |
None |
10.1021/jm00190a006 |
| Streptococcus mutans |
Streptococcus mutans |
log(1/MIC) |
5.3 |
None |
10.1021/jm00190a006 |
| Streptococcus mutans |
Streptococcus mutans |
MIC |
0.312 |
ug.mL-1 |
10.1021/np9901579 |
| Streptococcus mutans |
Streptococcus mutans |
MIC |
1.25 |
ug.mL-1 |
10.1021/acs.jnatprod.1c01093 |
| Streptococcus mutans |
Streptococcus mutans |
MIC |
2.0 |
ug.mL-1 |
10.1128/aac.00999-06 |
| Streptococcus mutans |
Streptococcus mutans |
MIC |
3000.0 |
nM |
10.1016/j.ejmech.2007.11.001 |
| Streptococcus mutans |
Streptococcus mutans |
Min plague Inhibitory |
0.005 |
% |
10.1021/jm00377a014 |
| Streptococcus mutans |
Streptococcus mutans |
PBI |
25.6 |
None |
10.1021/jm00377a014 |
| Streptococcus mutans |
Streptococcus mutans |
Plaque accum |
nan |
None |
10.1021/jm00377a014 |
| Streptococcus mutans |
Streptococcus mutans |
Staining potential |
nan |
None |
10.1021/jm00377a014 |
| Streptococcus oralis |
Streptococcus oralis |
Inhibition |
95.0 |
% |
10.1128/aac.01391-09 |
| Streptococcus salivarius |
Streptococcus salivarius |
Inhibition |
95.0 |
% |
10.1128/aac.01391-09 |
| Streptococcus sanguinis |
Streptococcus sanguinis |
Inhibition |
95.0 |
% |
10.1128/aac.01391-09 |
| Streptococcus sanguinis |
Streptococcus sanguinis |
PBI |
32.0 |
None |
10.1021/jm00377a014 |
| Streptococcus sobrinus |
Streptococcus sobrinus |
MBC |
2.0 |
uM |
10.1021/acs.jnatprod.9b01045 |
| Streptococcus sobrinus |
Streptococcus sobrinus |
MBC |
3.2 |
mM |
10.1021/jm00118a030 |
| Streptococcus sobrinus |
Streptococcus sobrinus |
MIC |
2000.0 |
nM |
10.1021/acs.jnatprod.9b01045 |
| Streptococcus sobrinus |
Streptococcus sobrinus |
PBI |
25.6 |
None |
10.1021/jm00118a030 |
| Treponema denticola |
Treponema denticola |
MIC |
2.2 |
ug.mL-1 |
10.1021/acs.jnatprod.1c01093 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
EC50 |
530.0 |
nM |
10.1021/acs.jmedchem.7b00405 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
EC50 |
670.0 |
nM |
10.1021/acs.jmedchem.7b00405 |
| Trypanosoma cruzi |
Cruzipain |
Potency |
31622.8 |
nM |
None |
| Trypanosoma cruzi |
Cruzipain |
Potency |
39810.7 |
nM |
None |
| Trypanosoma cruzi |
Trypanothione reductase |
Ki |
2000.0 |
nM |
10.1021/jm050027z |
| None |
ADMET |
LD50 |
1260.0 |
mg.kg-1 |
10.1016/j.ejmech.2020.113100 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LTKB_BD DILI severity score |
nan |
None |
10.1016/j.drudis.2011.05.007 |
| None |
HSF (VGS) |
CC50 |
5.48 |
ug.mL-1 |
10.1016/j.bmc.2020.115905 |
| None |
Molecular identity unknown |
Potency |
39810.7 |
nM |
None |
| None |
Molecular identity unknown |
Potency |
42163.2 |
nM |
None |
| None |
NON-PROTEIN TARGET |
EC50 |
321.0 |
nM |
10.1016/j.bmcl.2016.11.036 |
| None |
NON-PROTEIN TARGET |
EC50 |
349.0 |
nM |
10.1016/j.bmcl.2016.11.036 |
| None |
NON-PROTEIN TARGET |
EC50 |
410.0 |
nM |
10.1021/acsmedchemlett.6b00276 |
| None |
NON-PROTEIN TARGET |
EC50 |
430.0 |
nM |
10.1021/acsmedchemlett.6b00276 |
| None |
NON-PROTEIN TARGET |
EC50 |
440.0 |
nM |
10.1016/j.bmcl.2016.11.036 |
| None |
NON-PROTEIN TARGET |
EC50 |
321366.05 |
nM |
10.1016/j.bmcl.2016.11.036 |
| None |
NON-PROTEIN TARGET |
EC50 |
349945.17 |
nM |
10.1016/j.bmcl.2016.11.036 |
| None |
NON-PROTEIN TARGET |
EC50 |
440554.86 |
nM |
10.1016/j.bmcl.2016.11.036 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
No relevant target |
LogP |
4.51 |
None |
10.1016/j.ejmech.2020.113100 |
| None |
No relevant target |
LogP |
4.78 |
None |
10.1021/jm00190a006 |
| None |
No relevant target |
pKa |
10.78 |
None |
10.1021/jm00190a006 |
| None |
No relevant target |
pKa |
10.8 |
None |
10.1016/j.ejmech.2021.113378 |
| None |
Unchecked |
Ac50 |
39.81 |
uM |
None |
| None |
Unchecked |
AC50 |
5270.0 |
nM |
None |
| None |
Unchecked |
AC50 |
12250.0 |
nM |
None |
| None |
Unchecked |
AC50 |
12510.0 |
nM |
None |
| None |
Unchecked |
AC50 |
13610.0 |
nM |
None |
| None |
Unchecked |
AC50 |
13750.0 |
nM |
None |
| None |
Unchecked |
AC50 |
13860.0 |
nM |
None |
| None |
Unchecked |
AC50 |
15600.0 |
nM |
None |
| None |
Unchecked |
AC50 |
16380.0 |
nM |
None |
| None |
Unchecked |
AC50 |
20020.0 |
nM |
None |
| None |
Unchecked |
AC50 |
21590.0 |
nM |
None |
| None |
Unchecked |
AC50 |
33880.0 |
nM |
None |
| None |
Unchecked |
AC50 |
39810.7 |
nM |
None |
| None |
Unchecked |
CC50 |
5.12 |
ug.mL-1 |
10.1016/j.ejmech.2020.113100 |
| None |
Unchecked |
EC50 |
178.0 |
nM |
None |
| None |
Unchecked |
EC50 |
649.0 |
nM |
None |
| None |
Unchecked |
EC50 |
2900.0 |
nM |
None |
| None |
Unchecked |
EC50 |
3910.0 |
nM |
None |
| None |
Unchecked |
EC50 |
6744.0 |
nM |
None |
| None |
Unchecked |
EC50 |
101482.0 |
nM |
None |
| None |
Unchecked |
Hepatotoxicity (acute) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
438.6 |
nM |
None |
| None |
Unchecked |
IC50 |
1345.5 |
nM |
None |
| None |
Unchecked |
IC50 |
1655.0 |
nM |
None |
| None |
Unchecked |
IC50 |
2803.1 |
nM |
None |
| None |
Unchecked |
IC50 |
3785.2 |
nM |
None |
| None |
Unchecked |
IC50 |
4022.0 |
nM |
None |
| None |
Unchecked |
IC50 |
4385.3 |
nM |
None |
| None |
Unchecked |
IC50 |
4580.1 |
nM |
None |
| None |
Unchecked |
IC50 |
5130.0 |
nM |
None |
| None |
Unchecked |
IC50 |
5163.1 |
nM |
None |
| None |
Unchecked |
IC50 |
5260.0 |
nM |
None |
| None |
Unchecked |
IC50 |
5354.0 |
nM |
None |
| None |
Unchecked |
IC50 |
5666.4 |
nM |
None |
| None |
Unchecked |
IC50 |
6707.2 |
nM |
None |
| None |
Unchecked |
IC50 |
9090.0 |
nM |
None |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
None |
| None |
Unchecked |
IC50 |
10328.7 |
nM |
None |
| None |
Unchecked |
IC50 |
14630.0 |
nM |
None |
| None |
Unchecked |
IC50 |
14920.0 |
nM |
None |
| None |
Unchecked |
IC50 |
20000.0 |
nM |
None |
| None |
Unchecked |
IC50 |
25179.2 |
nM |
None |
| None |
Unchecked |
IC50 |
26202.73 |
nM |
None |
| None |
Unchecked |
IC50 |
31818.0 |
nM |
None |
| None |
Unchecked |
Potency |
2511.9 |
nM |
None |
| None |
Unchecked |
Potency |
7079.5 |
nM |
None |
| None |
Unchecked |
Potency |
8912.5 |
nM |
None |
| None |
Unchecked |
Potency |
10000.0 |
nM |
None |
| None |
Unchecked |
Potency |
12589.3 |
nM |
None |
| None |
Unchecked |
Potency |
14125.4 |
nM |
None |
| None |
Unchecked |
Potency |
15848.9 |
nM |
None |
| None |
Unchecked |
Potency |
18356.4 |
nM |
None |
| None |
Unchecked |
Potency |
22387.2 |
nM |
None |
| None |
Unchecked |
Potency |
28183.8 |
nM |
None |
| None |
Unchecked |
Potency |
29092.9 |
nM |
None |
| None |
Unchecked |
Potency |
31622.8 |
nM |
None |
| None |
Unchecked |
Potency |
40533.4 |
nM |
None |
| None |
Unchecked |
Ratio |
1.37 |
None |
10.1016/j.bmc.2020.115905 |
| None |
Unchecked |
Ratio |
2.74 |
None |
10.1016/j.bmc.2020.115905 |
| None |
Unchecked |
Ratio |
5.48 |
None |
10.1016/j.bmc.2020.115905 |
| None |
Unchecked |
Stain index |
1.0 |
None |
10.1021/jm00377a014 |